Efficacy of ibrutinib in a patient with transformed lymphoplasmacytic lymphoma and central nervous system involvement

被引：10
|
作者：
Hiemcke-Jiwa, Laura S. [1 ]
Leguit, Roos J. [1 ]
Radersma-van Loon, Joyce H. [1 ]
Westerweel, Peter E. [2 ]
Rood, Johannes J. M. [3 ]
Doorduijn, Jeanette K. [4 ]
Huibers, Manon M. H. [1 ]
Minnema, Monique C. [5 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
[2] Albert Schweitzer Hosp Dordrecht, Dept Internal Med, Dordrecht, Netherlands
[3] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Dept Pharmaceut Sci, Fac Sci, Utrecht, Netherlands
[4] Erasmus Canc Inst Rotterdam, Dept Hematol, Rotterdam, Netherlands
[5] Univ Med Ctr Utrecht, Dept Hematol, Canc Ctr, Utrecht, Netherlands
来源：
LEUKEMIA & LYMPHOMA | 2018年 / 59卷 / 05期
关键词：
CHRONIC LYMPHOCYTIC-LEUKEMIA; B-CELL LYMPHOMA; WALDENSTROM MACROGLOBULINEMIA; INHIBITOR IBRUTINIB; MUTATION;
D O I：
10.1080/10428194.2017.1369074
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1256 / 1259
页数：4
相关论文
共 50 条
  • [1] Ibrutinib response in cutaneous transformed lymphoplasmacytic lymphoma
    Lindholm, Kaleigh E.
    Forsberg, Peter A.
    Ewalt, Mark D.
    [J]. EJHAEM, 2021, 2 (03): : 565 - 568
  • [2] Ibrutinib as salvage therapy in mantle cell lymphoma with central nervous system involvement in a pretreated unfit patient
    Vitagliano, Orsola
    Trastulli, Fabio
    Cacace, Fabiana
    Leone, Stefania
    Memoli, Mara
    Scalia, Giulia
    Notarangelo, Marianna
    Mainolfi, Ciro G.
    De Renzo, Amalia
    Pane, Fabrizio
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1734 - 1737
  • [3] Preclinical Evaluation of Ibrutinib for Central Nervous System Lymphoma
    Pouzoulet, Frederic
    Rezai, Keyvan
    Li, Zhimin
    Qiu Yushi
    Tun, Han W.
    Labiod, Dalila
    Bonnet-Boissinot, Sarah
    Soussain, Carole
    [J]. BLOOD, 2016, 128 (22)
  • [4] Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement
    Furqan, Fateeha
    Watson, Grace
    Samaniego, Felipe
    Fayad, Luis E.
    Kanagal-Shamanna, Rashmi
    Morrison, Michael W.
    Thompson, Philip A.
    Steiner, Raphael E.
    Chi, Linda
    Dabaja, Bouthaina
    Pinnix, Chelsea C.
    Neelapu, Sattva S.
    Nastoupil, Loretta J.
    Strati, Paolo
    [J]. LEUKEMIA & LYMPHOMA, 2020, 61 (12) : 2980 - 2984
  • [5] CENTRAL-NERVOUS-SYSTEM INVOLVEMENT IN LYMPHOMA
    REICH, EG
    MONTEVERDE, DA
    [J]. NEUROLOGY, 1994, 44 (04) : A406 - A406
  • [6] Efficacy and Safety of Liposomal Cytarabine in Lymphoma Patients With Central Nervous System Involvement From Lymphoma
    Garcia-Marco, Jose A.
    Panizo, Carlos
    Sanchez Garcia, Eva
    Deben, Guillermo
    Alvarez-Larran, Alberto
    Gonzalez Barca, Eva
    Manuel Sancho, Juan
    Jesus Penarrubia, Maria
    Garcia-Cerecedo, Tomas
    Garcia Vela, Jose A.
    [J]. CANCER, 2009, 115 (09) : 1892 - 1898
  • [7] Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemia
    Wanquet, Anne
    Birsen, Rudy
    Lemal, Richard
    Hunault, Mathilde
    Leblond, Veronique
    Aurran-Schleinitz, Therese
    [J]. BLOOD, 2016, 127 (19) : 2356 - 2358
  • [8] Eye involvement in primary central nervous system lymphoma
    Farrall, Alexandra L.
    Smith, Justine R.
    [J]. SURVEY OF OPHTHALMOLOGY, 2020, 65 (05) : 548 - 561
  • [9] Hyponatremia in a Patient With Central Nervous System Lymphoma
    Brault, Clement
    Flahaut, Gauthier
    Maizel, Julien
    Choukroun, Gabriel
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 68 (01) : XVII - XIX
  • [10] CENTRAL NERVOUS SYSTEM INVOLVEMENT OF PATIENTS WITH BREAST LYMPHOMA
    Fritsch, K.
    Kasenda, B.
    Schorb, E.
    Finke, J.
    Illerhaus, G.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 196 - 196
12345